(CG) Carlyle - Ratings and Ratios
Private Equity, Real Assets, Credit, Infrastructure, Venture
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.57% |
| Yield on Cost 5y | 5.77% |
| Yield CAGR 5y | 8.78% |
| Payout Consistency | 91.2% |
| Payout Ratio | 35.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 35.7% |
| Value at Risk 5%th | 58.0% |
| Relative Tail Risk | -1.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.23 |
| Alpha | -21.10 |
| CAGR/Max DD | 0.63 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.426 |
| Beta | 1.715 |
| Beta Downside | 2.108 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.53% |
| Mean DD | 11.39% |
| Median DD | 9.80% |
Description: CG Carlyle October 16, 2025
The Carlyle Group Inc. (NASDAQ: CG) is a global alternative-asset manager that deploys capital through both direct investments and fund-of-fund structures, targeting a broad spectrum of strategies from leveraged buyouts and distressed credit to venture-stage growth and structured finance.
Its operations are organized into four core segments-Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions-allowing it to invest across more than 30 industries, including industrial manufacturing, aerospace & defense, fintech, renewable energy, and consumer retail. This diversification lets Carlyle capture value from macro-driven trends such as infrastructure spending, ESG-focused capital flows, and the ongoing digital transformation of traditional sectors.
As of the most recent filing, Carlyle reported approximately $426 billion in assets under management, generating $5.2 billion of revenue in 2023 with a net income margin of roughly 12 %, while fee-related earnings grew 8 % year-over-year, reflecting strong fundraising momentum and higher fee-related earnings from its expanding private-equity and real-asset platforms. For investors seeking deeper quantitative analysis, a look-up on ValueRay can provide granular, up-to-date performance metrics and scenario modeling tools.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (342.7m TTM) > 0 and > 6% of Revenue (6% = 185.3m TTM) |
| FCFTA -0.09 (>2.0%) and ΔFCFTA -8.33pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 97.14% (prev 83.71%; Δ 13.43pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.09 (>3.0%) and CFO -2.43b <= Net Income 342.7m (YES >=105%, WARN >=100%) |
| Net Debt (8.92b) to EBITDA (664.7m) ratio: 13.43 <= 3.0 (WARN <= 3.5) |
| Current Ratio 22.63 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (360.1m) change vs 12m ago -1.46% (target <= -2.0% for YES) |
| Gross Margin 83.68% (prev 76.77%; Δ 6.91pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 12.43% (prev 12.98%; Δ -0.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.73 (EBITDA TTM 664.7m / Interest Expense TTM 711.2m) >= 6 (WARN >= 3) |
Altman Z'' 1.15
| (A) 0.11 = (Total Current Assets 3.14b - Total Current Liabilities 138.7m) / Total Assets 27.06b |
| (B) 0.06 = Retained Earnings (Balance) 1.62b / Total Assets 27.06b |
| (C) 0.02 = EBIT TTM 522.2m / Avg Total Assets 24.86b |
| (D) 0.08 = Book Value of Equity 1.62b / Total Liabilities 20.21b |
| Total Rating: 1.15 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 26.23
| 1. Piotroski 2.50pt |
| 2. FCF Yield -10.09% |
| 3. FCF Margin -81.50% |
| 4. Debt/Equity 1.69 |
| 5. Debt/Ebitda 13.43 |
| 6. ROIC - WACC (= -4.87)% |
| 7. RoE 5.80% |
| 8. Rev. Trend -5.07% |
| 9. EPS Trend -30.00% |
What is the price of CG shares?
Over the past week, the price has changed by +5.43%, over one month by -4.88%, over three months by -14.78% and over the past year by +5.18%.
Is CG a buy, sell or hold?
- Strong Buy: 4
- Buy: 3
- Hold: 10
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 65.4 | 19.9% |
| Analysts Target Price | 65.4 | 19.9% |
| ValueRay Target Price | 57.2 | 5% |
CG Fundamental Data Overview November 25, 2025
P/E Trailing = 29.0562
P/E Forward = 10.3842
P/S = 5.8309
P/B = 3.3177
P/EG = 0.9112
Beta = 2.057
Revenue TTM = 3.09b USD
EBIT TTM = 522.2m USD
EBITDA TTM = 664.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 458.2m USD (from shortTermDebt, last fiscal year)
Debt = 9.50b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 8.92b USD (from netDebt column, last quarter)
Enterprise Value = 24.94b USD (18.71b + Debt 9.50b - CCE 3.26b)
Interest Coverage Ratio = 0.73 (Ebit TTM 522.2m / Interest Expense TTM 711.2m)
FCF Yield = -10.09% (FCF TTM -2.52b / Enterprise Value 24.94b)
FCF Margin = -81.50% (FCF TTM -2.52b / Revenue TTM 3.09b)
Net Margin = 11.10% (Net Income TTM 342.7m / Revenue TTM 3.09b)
Gross Margin = 83.68% ((Revenue TTM 3.09b - Cost of Revenue TTM 504.1m) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 73.47%)
Tobins Q-Ratio = 0.92 (Enterprise Value 24.94b / Total Assets 27.06b)
Interest Expense / Debt = 2.18% (Interest Expense 207.1m / Debt 9.50b)
Taxrate = -31.12% (negative due to tax credits) (-26.7m / 85.8m)
NOPAT = 684.7m (EBIT 522.2m * (1 - -31.12%)) [negative tax rate / tax credits]
Current Ratio = 22.63 (Total Current Assets 3.14b / Total Current Liabilities 138.7m)
Debt / Equity = 1.69 (Debt 9.50b / totalStockholderEquity, last quarter 5.62b)
Debt / EBITDA = 13.43 (Net Debt 8.92b / EBITDA 664.7m)
Debt / FCF = -3.55 (negative FCF - burning cash) (Net Debt 8.92b / FCF TTM -2.52b)
Total Stockholder Equity = 5.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.27% (Net Income 342.7m / Total Assets 27.06b)
RoE = 5.80% (Net Income TTM 342.7m / Total Stockholder Equity 5.91b)
RoCE = 1.94% (EBIT 522.2m / Capital Employed (Total Assets 27.06b - Current Liab 138.7m))
RoIC = 4.28% (NOPAT 684.7m / Invested Capital 16.01b)
WACC = 9.15% (E(18.71b)/V(28.20b) * Re(12.34%) + D(9.50b)/V(28.20b) * Rd(2.18%) * (1-Tc(-0.31)))
Discount Rate = 12.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.09%
Fair Price DCF = unknown (Cash Flow -2.52b)
EPS Correlation: -30.00 | EPS CAGR: -17.89% | SUE: -0.73 | # QB: 0
Revenue Correlation: -5.07 | Revenue CAGR: -20.98% | SUE: -0.50 | # QB: 0
Additional Sources for CG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle